focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCAY.L Regulatory News (CAY)

  • There is currently no data for CAY

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Charles Stanley Group Plc

2 Aug 2021 15:20

Aberforth Partners LLP - Form 8.3 - Charles Stanley Group Plc

Aberforth Partners LLP - Form 8.3 - Charles Stanley Group Plc

PR Newswire

London, August 2

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON

WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:Aberforth Partners LLP, on behalf of discretionary clients.
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.N/A
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Charles Stanley Group plc
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:N/A
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure 30/07/2021
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”YES / NO / N/A NO If YES, specify which:

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: Ordinary Shares
InterestsShort positions
Number%Number%
(1) Relevant securities owned and/or controlled: 4,563,777 8.75% 0 0.0
(2) Cash-settled derivatives:
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:
TOTAL: 4,563,777 8.75% 0 0.0

Aberforth Partners LLP does not have discretion regarding voting decisions in respect of 1,399,602 shares included in the total disclosed above. This total includes 1,399,602 shares held by The Wellcome Trust, who retain voting control over their shareholding. No other client, who falls into this category, holds more than 1% of the relevant security.

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:N/A
Details, including nature of the rights concerned and relevant percentages:N/A

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchase/saleNumber of securitiesPrice per unit
Ordinary Shares Sale 3,500,000  510.3p

(b) Cash-settled derivative transactions

Class of relevant securityProduct description e.g. CFDNature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit
N/A

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitType e.g. American, European etc.Expiry dateOption money paid/ received per unit
N/A

(ii) Exercise

Class of relevant securityProduct description e.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit
N/A

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealing e.g. subscription, conversionDetailsPrice per unit (if applicable)
N/A

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none”
None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?NO

Date of disclosure: 02 August 2021
Contact name:Michael Campbell, for Aberforth Partners LLP
Telephone number:0131 220 0733

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Date   Source Headline
18th Dec 20199:16 amRNSDirector/PDMR Shareholding
13th Dec 201910:28 amRNSDirector/PDMR Shareholding
11th Dec 20192:10 pmRNSHolding(s) in Company
11th Dec 20199:30 amRNSHolding(s) in Company
10th Dec 20194:16 pmRNSHolding(s) in Company
29th Nov 201910:39 amRNSTotal Voting Rights
25th Nov 201911:33 amRNSInterim Results Correction Notice
21st Nov 20193:07 pmRNSAppointment of External Auditor
21st Nov 20197:00 amRNSInterim Results
20th Nov 201911:28 amRNSHolding(s) in Company
11th Nov 201910:10 amRNSDirector/PDMR Shareholding
8th Nov 20197:00 amRNSNotice of Interim Results
31st Oct 20199:56 amRNSTotal Voting Rights
22nd Oct 20192:26 pmRNSHolding(s) in Company
11th Oct 20191:21 pmRNSDirector/PDMR Shareholding
11th Oct 20199:43 amRNSTR-1 NOTIFICATION
30th Sep 201911:35 amRNSTotal Voting Rights
20th Sep 20193:42 pmRNSDirector Declaration
13th Sep 20191:03 pmRNSDirector/PDMR Shareholding
30th Aug 201912:15 pmRNSTotal Voting Rights
9th Aug 201912:44 pmRNSDirector/PDMR Shareholding
1st Aug 20199:00 amRNSAcquisition
31st Jul 20199:58 amRNSTotal Voting Rights
26th Jul 201912:30 pmRNSDirector/PDMR Shareholding
26th Jul 201912:13 pmRNSHolding(s) in Company
18th Jul 20194:05 pmRNSDirector/PDMR Shareholding
18th Jul 201911:23 amRNSBlock Listing Application
15th Jul 20193:34 pmRNSHolding(s) in Company
12th Jul 201911:43 amRNSDirector/PDMR Shareholding
11th Jul 20197:00 amRNSResult of AGM
10th Jul 20197:00 amRNSTrading Update
4th Jul 20193:41 pmRNSHolding(s) in Company
1st Jul 20191:00 pmRNSTotal Voting Rights
27th Jun 20191:10 pmRNSBlock Listing Application
26th Jun 201912:46 pmRNSDirector/PDMR Shareholding
26th Jun 201912:43 pmRNSDirector/PDMR Shareholding
14th Jun 20191:08 pmRNSDirector/PDMR Shareholding
12th Jun 20191:15 pmRNSTR-1
10th Jun 20193:59 pmRNSAnnual Financial Report
31st May 201910:52 amRNSTotal Voting Rights
31st May 20197:00 amRNSResults for the year ended 31 March 2019
23rd May 201911:18 amRNSHolding(s) in Company
22nd May 201912:39 pmRNSDirectorate Change
13th May 201911:08 amRNSDirector/PDMR Shareholding
9th May 20197:00 amRNSRestructure of Operating Model
3rd May 20192:48 pmRNSHolding(s) in Company
1st May 201911:35 amRNSHolding(s) in Company
30th Apr 20193:07 pmRNSTotal Voting Rights
18th Apr 20194:36 pmRNSPrice Monitoring Extension
15th Apr 201911:45 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.